Graphene quantum dots redefine nanobiomedicine

Area of Science:

• Nanomedicine
• Materials Science
• Biotechnology

Background:

• Carbon-based nanomaterials are widely used as drug delivery carriers.
• Graphene quantum dots (GQDs) are emerging as versatile carbon nanostructures with unique properties.
• Recent research highlights GQDs' potential in various biomedical applications.

Purpose of the Study:

• To review the therapeutic, drug delivery, biosensing, and bioimaging applications of graphene quantum dots (GQDs).
• To explore the potential of GQDs as therapeutic agents themselves, not just carriers.
• To speculate on the future role of GQDs in nanobiomedicine.

Main Methods:

• Literature review of studies on graphene quantum dots (GQDs).
• Analysis of reported therapeutic effects, drug delivery capabilities, and diagnostic applications of GQDs.
• Synthesis of information regarding GQD potential in neurodegenerative diseases, infections, and cancer therapy.

Main Results:

• Graphene quantum dots (GQDs) exhibit therapeutic potential for Parkinson's and Alzheimer's diseases.
• GQDs demonstrate antibacterial and anti-diabetic properties.
• GQDs show promise for drug delivery across the blood-brain barrier and for tumor-targeted delivery.
• Biosensing and bioimaging applications of GQDs are under extensive investigation.

Conclusions:

• Graphene quantum dots (GQDs) represent a significant advancement in nanomedicine, offering therapeutic benefits and versatile drug delivery capabilities.
• The dual role of GQDs as therapeutic agents and drug delivery systems positions them as a next-generation strategy for complex diseases.
• Further research into GQD applications is expected to drive innovation in nanobiomedicine and address unmet therapeutic needs.